Clinical trials
Placebo clinical trials
Below are recruiting placebo clinical trials, each written for real people, not researchers. We’re tracking 5,158 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06887192RecruitingPhase 2
Testing ML-007C-MA for Alzheimer's Psychosis
This trial tests a study drug called ML-007C-MA to see if it can safely reduce hallucinations and delusions in people with Alzheimer's disease who also have psychosis. If you or your loved one has Alzheimer's and has been experiencing false beliefs or seeing/hearing things that aren't there for at least two months, this study may be an option.
Phoenix, ArizonaAges 55–90 - NCT06882785RecruitingPhase 3
Testing KarXT for Japanese adults with schizophrenia
This trial tests a new medication called KarXT for people with schizophrenia who are currently having a psychotic episode. It is for Japanese adults who have had schizophrenia before and are not in their first episode.
Kōnan, Aichi-kenAges 18–65 - NCT06883058Enrolling by invitation
CASA Program for Distressed Patients and Caregivers
This trial tests a program called CASA that helps both patients with advanced cancer and their caregivers cope with distress. If you or your loved one feel overwhelmed by worry or sadness, this support program may help you manage those feelings together.
Ponce, PRAges 21–105 - NCT06880276RecruitingPhase 3
Studying QLM3003 ointment for mild or moderate eczema
This trial tests if an ointment called QLM3003 is safe and helps adults with mild to moderate atopic dermatitis (eczema). It may be a new treatment option for people whose eczema affects small areas of skin.
ShenyangAges 18–75 - NCT04372615RecruitingPhase 2
Inebilizumab for NMDA receptor encephalitis after initial steroids
This Phase 2 study tests inebilizumab in people with NMDA receptor encephalitis, an immune-related brain condition. It looks to see if adding this treatment after starting steroids (and possibly other first treatments) improves recovery and safety.
Birmingham, AlabamaAges 12 years+ - NCT06886464RecruitingPhase 2
Preventing kidney injury from strong medications with cilastatin
This study tests whether a medicine called cilastatin can prevent kidney damage caused by certain strong medications. If you are receiving one of these medications and are at risk for kidney injury, this trial may offer protection.
Calgary, AlbertaAges 18 years+ - NCT06889961Recruiting
Daily mixed spice consumption for memory health
This trial tests whether eating a mix of spices every day can help improve memory in older adults with mild memory changes. If you are between 50 and 80 and have no major health conditions, you may be able to join.
Los Angeles, CaliforniaAges 50–80 - NCT06889753RecruitingPhase 2
Pollen extract for menopause symptoms in healthy women
This study tests if a natural pollen extract can help reduce common menopause symptoms like hot flashes, night sweats, and sleep or mood issues. It is for healthy women who are postmenopausal and experiencing at least moderate symptoms.
London, OntarioAges 45–65 - NCT06880484Enrolling by invitation
Far-infrared socks for diabetic nerve pain
This study tests whether special far-infrared socks can help relieve nerve pain and improve nerve function in people with diabetic nerve damage. If you have mild to moderate nerve pain and live in Kayseri, you may be able to join.
Talas, KayseriAges 19 years+ - NCT06889389Recruiting
Education and exercise for neck pain relief
This study tests if combining education with exercise can reduce pain and improve function for people with non-specific neck pain (pain not caused by a specific injury or disease). Participants will learn about their condition and do guided exercises.
Elche, AlicanteAges 18–65 - NCT06882824Recruiting
Preventing bleeding during fibroid surgery with misoprostol
This trial tests if giving misoprostol before surgery can reduce blood loss during the removal of uterine fibroids (non-cancerous growths). It is for women who need laparoscopic or open surgery for their fibroids.
Clermont-Ferrand, Clermont-FerrandAges 18–43 - NCT06889168RecruitingPhase 1
Long-term safety of imatinib for LAM
This study tests the long-term safety and tolerability of the drug imatinib in women with LAM, a rare lung disease that causes cysts. It may help stabilize lung function over time.
New York, New YorkAges 18–64 - NCT06055179Recruiting
Herbal medicine for diarrhea from irinotecan chemo
This study tests if a Chinese herbal formula (XCHT) can reduce diarrhea caused by the chemo drug irinotecan. If you are getting irinotecan and already had troublesome diarrhea, you may be able to join and get supportive treatment.
Guangzhou, GuangdongAges 18–75 - NCT06874452RecruitingPhase 4
Anti-anxiety pill for second cataract surgery
This study tests if giving the anti-anxiety pill alprazolam (XANAX) before your second cataract surgery helps reduce anxiety and improve satisfaction with the procedure.
TaipeiAges 18–80 - NCT06876129RecruitingPhase 1
Adding D-serine to TMS for depression
This trial tests whether adding a medication called D-serine to a brain stimulation treatment (TMS) helps improve depression. It’s for adults with major depression who are already getting TMS therapy.
Belmont, MassachusettsAges 18–80 - NCT06874855RecruitingPhase 4
Study of sleep medication for delayed sleep phase syndrome
This trial tests whether a sleep medication called lemborexant can help people with delayed sleep phase syndrome fall asleep earlier. It may improve sleep timing and reduce the impact on daily life.
San Francisco, CaliforniaAges 18 years+ - NCT06871488RecruitingPhase 4
ADHD irritability & aggression treatment with stimulants
This study tests whether CNS stimulant medications can improve irritability and aggression in children with ADHD. It looks for factors that predict who will benefit most.
Hershey, PennsylvaniaAges 7–12 - NCT06878417Recruiting
Cannabinoids for osteoarthritis knee or hip pain
This study tests if cannabinoid medications can reduce pain interference in daily life for people with hip or knee osteoarthritis. It may be a new option for moderate to severe pain.
Toronto, OntarioAges 40–80 - NCT06869551RecruitingPhase 3
Testing a New Drug for Juvenile Psoriatic Arthritis
This study tests an investigational drug called Deucravacitinib to see if it can safely and effectively treat Juvenile Psoriatic Arthritis in children. You may be able to join if standard treatments haven't helped enough.
Lancaster, CaliforniaAges 5–17 - NCT06878976Enrolling by invitationPhase 3
Long-term safety of solriamfetol for binge eating disorder
This study looks at the long-term safety and effectiveness of the medication solriamfetol for people with binge eating disorder. If you were in the earlier SOL-BED-301 study, this gives you a chance to continue treatment and see how it works over a longer time.
Encino, CaliforniaAges 18–56 - NCT06872892RecruitingPhase 3
Study of BI 1291583 for people with bronchiectasis
This trial tests whether a new medication, BI 1291583, can help people with bronchiectasis reduce lung infections and symptoms. You may join if you have had at least one or two lung flare-ups in the past year.
Birmingham, AlabamaAges 12 years+ - NCT06878261RecruitingPhase 3
Tezepelumab for moderate to very severe COPD
This study tests a new medication called tezepelumab (given as a shot) to see if it can reduce COPD flare-ups in people with moderate to very severe COPD who have had recent flare-ups despite using inhalers. It may be an option for those with higher levels of eosinophils (a type of white blood cell) in their blood.
Birmingham, AlabamaAges 40–80 - NCT06859073RecruitingPhase 1
Safety study of NNC4004-0002 for high uric acid without symptoms
This study tests a new medicine, NNC4004-0002, for people who have high uric acid levels but no gout symptoms. The goal is to see if it is safe and how well it works in healthy adults aged 35 to 75.
Glendale, CaliforniaAges 35–75 - NCT06866405RecruitingPhase 3
RSV vaccine boost in a new pregnancy
This study tests whether a second dose of the RSV vaccine during a new pregnancy protects you and your baby from RSV. If you received the RSVpreF or Abrysvo vaccine in a past pregnancy, you may be able to join.
Birmingham, AlabamaAges birth+
Hear when a new Placebo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo?
- Yes. Clin2 currently lists 5,158 recruiting placebo studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.